Alibaba stock surges 12% on AI optimism and court win

1 min read     Updated on 08 Jul 2026, 03:26 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Alibaba Group Holding Ltd. saw its stock surge nearly 12% in premarket trading driven by improved earnings outlook and AI developments. The company reported narrowing losses in its instant-commerce business and stable profitability. Jefferies analyst Thomas Chong expressed confidence in solid execution and accelerated AliCloud growth. Additionally, Alibaba banned employees from using Anthropic's products, opting for its in-house Qoder assistant, and secured temporary legal relief from a Pentagon lobbying restriction. Upcoming earnings on Aug. 28, 2026, remain a key focus, with EPS projected at $2.51.

powered bylight_fuzz_icon
44877106

*this image is generated using AI for illustrative purposes only.

Alibaba Group Holding Ltd. stock surged nearly 12% in premarket trading Wednesday as improving earnings expectations, artificial intelligence optimism, and several company developments boosted investor sentiment. The rally followed reports that Alibaba provided analysts with a positive business update ahead of earnings, indicating that losses in its instant-commerce business narrowed during the June quarter while overall profitability remained stable. Shares were up 11.34% at $109.27 during premarket trading.

Jefferies Sees Stronger Execution

Alibaba shares have fallen more than 33% year to date as investors worried about China’s slowing economy and questioned how quickly the company could monetize its AI investments. However, Jefferies Hong Kong analyst Thomas Chong believes much of that pessimism is already reflected in the stock price. Chong expects Alibaba to deliver solid execution in the June quarter and anticipates AliCloud to post faster year-over-year growth, supported by rising demand for AI services.

Anthropic Ban And Court Win Draw Attention

Alibaba also remained in focus after two major developments. The company instructed employees to stop using Anthropic’s AI products, effective July 10, classifying Anthropic’s Claude Code as high-risk software. Employees were directed to use Alibaba’s in-house AI assistant, Qoder, instead. This move followed Anthropic’s allegation that Alibaba attempted to distill its AI capabilities. Separately, U.S. District Judge Eumi K. Lee temporarily blocked the Defense Department from treating Alibaba as a military-linked company under a lobbying ban while the court reviews the company's constitutional challenge.

Earnings Remain The Next Key Catalyst

Investors are now looking ahead to Alibaba’s estimated Aug. 28, 2026, earnings report. Wall Street expects earnings per share of $2.51, up from $2.06 a year earlier. Revenue is projected to reach $38.72 billion, compared with $34.57 billion in the prior-year quarter. The stock trades at about 15.2 times earnings, suggesting a valuation that is broadly in line with peers.

Firm Rating Price Forecast
Susquehanna Positive $185
JPMorgan Overweight $205
Barclays Overweight $195

ETF Exposure Could Influence Trading

Alibaba is also a meaningful holding in several exchange-traded funds, including the Avantis Emerging Markets Equity ETF, the Avantis Responsible Emerging Markets Equity ETF, and the SPDR NYSE Technology ETF. Significant fund inflows or outflows could lead to automatic buying or selling of Alibaba shares.

How will the internal shift to Qoder impact Alibaba's ability to compete with other AI models in the long run?

What are the potential revenue implications if AliCloud achieves the accelerated growth forecast by Jefferies?

Could the court ruling regarding the 'military-linked' classification lead to a sustained re-rating of Alibaba's valuation?

like20
dislike

Alibaba agrees to $600M DOJ settlement over illegal drug sales

2 min read     Updated on 02 Jul 2026, 10:57 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Alibaba Group Holding Ltd. and AUS Merchant Services agreed to a $600 million non-prosecution agreement with the DOJ to resolve allegations of facilitating illegal pharmaceutical sales. The investigation revealed roughly 80,000 unlawful sales with a gross merchandise value exceeding $200 million between 2016 and 2024. Both companies admitted to compliance failures and agreed to financial penalties, while Alibaba also faces separate accusations regarding AI data harvesting.

powered bylight_fuzz_icon
44485298

*this image is generated using AI for illustrative purposes only.

Alibaba Group Holding Ltd. and U.S.-based payment processor AUS Merchant Services agreed to pay $600 million under a non-prosecution agreement to resolve allegations they failed to stop illegal pharmaceuticals and banned goods from reaching U.S. buyers through Alibaba’s online marketplaces. The settlement addresses claims that the companies' platforms facilitated transactions for items violating the Federal Food, Drug, and Cosmetic Act and other federal laws. This resolution concludes an investigation into compliance mechanisms, resolving claims without the companies admitting to the allegations.

According to the U.S. Department of Justice (DOJ), merchants using Alibaba.com and AliExpress carried out roughly 80,000 unlawful sales involving imports into the U.S. between January 2016 and December 2024. The sales included illegal pharmaceuticals, controlled substances, regulated chemicals, and pharmaceutical counterfeiting equipment, with a combined gross merchandise value exceeding $200 million. Federal investigators conducted more than 40 undercover purchases of illegal drugs and pill-making equipment during the probe.

Compliance Failures

The DOJ stated that Alibaba’s internal controls were not strong enough to prevent prohibited sellers from using its platforms. It also noted that some merchants used Alibaba’s private messaging tools and third-party encrypted apps to facilitate unlawful transactions. AUS, formerly known as Alipay U.S., admitted weaknesses in its anti-money-laundering compliance program. Court documents indicated the company failed to fully incorporate certain wire-transfer data into its transaction monitoring systems, causing it to miss some high-risk transactions. In at least one case, a merchant continued selling prohibited goods after being flagged.

Settlement Breakdown

The resolution involves a financial penalty and underscores the regulatory scrutiny on e-commerce platforms regarding product listings. The following table outlines the primary components of the agreement:

Entity Criminal Penalty Forfeiture Amount
Alibaba Group $125 million $200 million
AUS Merchant Services $85 million $190 million

Both companies agreed to strengthen compliance controls and continue cooperating with federal investigators. Assistant Attorney General Brett A. Shumate emphasized that companies operating online marketplaces must implement safeguards to stop bad actors from exploiting their platforms. Alibaba said it cooperated fully with the investigation and called the settlement a mutually satisfactory resolution.

Broader Scrutiny

The settlement comes as Alibaba faces broader scrutiny in the U.S. Last month, AI startup Anthropic accused the company of using thousands of fraudulent accounts to harvest nearly 28.8 million conversations from its Claude AI models. Alibaba did not publicly respond to that allegation. At the time of publication, Alibaba shares were down 1.58% at $96.44 in pre-market trading. The stock has traded between a 52-week high of $186.20 and a 52-week low of $88.65.

How will this settlement impact Alibaba's ability to attract and retain U.S. merchants on its platforms?

What specific technological upgrades will Alibaba and AUS implement to detect illicit transactions conducted via encrypted third-party apps?

Could this non-prosecution agreement set a legal precedent for increased regulatory scrutiny of other global e-commerce marketplaces?

like16
dislike

More News on Alibaba Group Holding Ltd